Results: The observer assessed ten LC videos, each involving a different surgeon.
2
As a result, a bright-to-dark transition of the LC image was observed.
3
Further study is needed to determine these specific subgroups of LC patients.
4
Five groups of Fuji II LC were investigated with different light-curing protocols.
5
Acres of Interior Space The LC 200 is indeed suited to families.
1
She had leptomeningealcarcinomatosis, in which cancer cells invade the fluid-filled membrane surrounding the brain.
2
Central nervous system disease was defined as one or more brain metastases or as leptomeningealcarcinomatosis.
3
Adequate early diagnosis and treatment of CVST enabled an excellent survival rate for the patient, despite leptomeningealcarcinomatosis.
4
Patients and methods: We report a case of leptomeningealcarcinomatosis secondary to endometrial carcinoma and 2 complex cervix cancer cases.
5
Effective treatment with gefitinib was administered, and the patient survived for 10 months after the diagnosis of CVST and leptomeningealcarcinomatosis.
1
A confirmatory phase 2 clinical trial is ongoing to assess ceritinib activity in patients with ALK-rearranged NSCLC and brain or leptomeningealmetastases.
1
A final diagnosis of mammary carcinoma with brain metastasis and meningealcarcinomatosis was made.
2
Prognosis of CNS relapse was worse for patients with meningealcarcinomatosis when compared with brain metastases.
1
Results: An aggressive variant of breast cancer was revealed: meningealmetastasis complicates less than 3.5% of cases of metastatic breast carcinoma.
1
Following chronic daily headache, neoplasticmeningitis was diagnosed in a non-smoking 44-year-old man.
2
This assumption was confirmed in xenotransplantation models for neoplasticmeningitis or solitary cerebral metastasis, where local virus treatment dramatically improved survival.
3
In addition, we tested an oncolytic PV recombinant for efficacy in xenotransplantation models of neoplasticmeningitis and cerebral metastasis secondary to breast cancer.
4
Neoplasticmeningitis (NM) is a relatively frequent metastatic complication of cancer associated with high levels of neurological morbidity and generally poor prognosis.
1
Moreover, the patient developed leptomeningealdisease in the spine.
Ús de carcinomatous meningitis en anglès
1
The median survival after diagnosis of carcinomatousmeningitis was 77 days.
2
Approximately 50% of patients with carcinomatousmeningitis die from other causes, including systemic disease.
3
Therefore, large studies to assess the value of CSF tumor marker changes in carcinomatousmeningitis are warranted.
4
Given our findings, CSF tumor marker evaluation may provide a reliable means and surrogate end-points of monitoring response of carcinomatousmeningitis to treatment.
5
Conclusions: Given our findings, CSF tumor marker evaluation may provide a reliable means and surrogate end-points of monitoring response of carcinomatousmeningitis to treatment.
6
Carcinomatousmeningitis (CM) is an uncommon but devastating complication of malignancy.
7
Conclusions: Carcinomatousmeningitis from breast carcinoma is an aggressive metastatic complication with a poor prognosis.
8
Background: Carcinomatousmeningitis is a rare and often devastating complication in patients with breast cancer, and the treatment is controversial.